216 related articles for article (PubMed ID: 36042205)
21. Mismatch repair deficiency may affect clinical outcome through immune response activation in metastatic gastric cancer patients receiving first-line chemotherapy.
Giampieri R; Maccaroni E; Mandolesi A; Del Prete M; Andrikou K; Faloppi L; Bittoni A; Bianconi M; Scarpelli M; Bracci R; Scartozzi M; Cascinu S
Gastric Cancer; 2017 Jan; 20(1):156-163. PubMed ID: 26796888
[TBL] [Abstract][Full Text] [Related]
22. Meta-analysis of associations between neutrophil-to-lymphocyte ratio and prognosis of gastric cancer.
Chen J; Hong D; Zhai Y; Shen P
World J Surg Oncol; 2015 Mar; 13():122. PubMed ID: 25889889
[TBL] [Abstract][Full Text] [Related]
23. Combined neutrophil/platelet/lymphocyte/differentiation score predicts chemosensitivity in advanced gastric cancer.
Huang Z; Liu Y; Yang C; Li X; Pan C; Rao J; Li N; Liao W; Lin L
BMC Cancer; 2018 May; 18(1):515. PubMed ID: 29720123
[TBL] [Abstract][Full Text] [Related]
24. Predictive value of neutrophil-to-lymphocyte ratio for distant metastasis in gastric cancer patients.
Zhang X; Wang X; Li W; Sun T; Diao D; Dang C
Sci Rep; 2022 Jun; 12(1):10269. PubMed ID: 35715490
[TBL] [Abstract][Full Text] [Related]
25. In Gastric Cancer Patients Receiving Neoadjuvant Chemotherapy Systemic Inflammation Response Index is a Useful Prognostic Indicator.
Chen L; Chen Y; Zhang L; Xue Y; Zhang S; Li X; Song H
Pathol Oncol Res; 2021; 27():1609811. PubMed ID: 34712105
[No Abstract] [Full Text] [Related]
26. Neutrophil-lymphocyte ratio is associated with prognosis in patients who underwent potentially curative resection for gastric cancer.
Szor DJ; Roncon Dias A; Pereira MA; Ramos MFKP; Zilberstein B; Cecconello I; Ribeiro U
J Surg Oncol; 2018 Apr; 117(5):851-857. PubMed ID: 29509963
[TBL] [Abstract][Full Text] [Related]
27. Pre-treatment Peripheral Neutrophil-Lymphocyte Ratio as a Prognostic Marker in Gastric Cancer.
Magdy M; Hussein T; Ezzat A; Gaballah A
J Gastrointest Cancer; 2019 Dec; 50(4):763-768. PubMed ID: 30058031
[TBL] [Abstract][Full Text] [Related]
28. Post-treatment neutrophil-to-lymphocyte ratio at week 6 is prognostic in patients with advanced non-small cell lung cancers treated with anti-PD-1 antibody.
Suh KJ; Kim SH; Kim YJ; Kim M; Keam B; Kim TM; Kim DW; Heo DS; Lee JS
Cancer Immunol Immunother; 2018 Mar; 67(3):459-470. PubMed ID: 29204702
[TBL] [Abstract][Full Text] [Related]
29. The implications of clinical risk factors, CAR index, and compositional changes of immune cells on hyperprogressive disease in non-small cell lung cancer patients receiving immunotherapy.
Kim SR; Chun SH; Kim JR; Kim SY; Seo JY; Jung CK; Gil BM; Kim JO; Ko YH; Woo IS; Shim BY; Hong SH; Kang JH
BMC Cancer; 2021 Jan; 21(1):19. PubMed ID: 33402127
[TBL] [Abstract][Full Text] [Related]
30. Metastasis Related Epithelial-Mesenchymal Transition Signature Predicts Prognosis and Response to Immunotherapy in Gastric Cancer.
Song J; Wei R; Huo S; Gao J; Liu X
Front Immunol; 2022; 13():920512. PubMed ID: 35769483
[TBL] [Abstract][Full Text] [Related]
31. Tumor Microenvironment Characterization for Assessment of Recurrence and Survival Outcome in Gastric Cancer to Predict Chemotherapy and Immunotherapy Response.
Chen Y; Sun Z; Wan L; Chen H; Xi T; Jiang Y
Front Immunol; 2022; 13():890922. PubMed ID: 35572498
[TBL] [Abstract][Full Text] [Related]
32. Radiomics to predict outcomes and abscopal response of patients with cancer treated with immunotherapy combined with radiotherapy using a validated signature of CD8 cells.
Sun R; Sundahl N; Hecht M; Putz F; Lancia A; Rouyar A; Milic M; Carré A; Battistella E; Alvarez Andres E; Niyoteka S; Romano E; Louvel G; Durand-Labrunie J; Bockel S; Bahleda R; Robert C; Boutros C; Vakalopoulou M; Paragios N; Frey B; Soria JC; Massard C; Ferté C; Fietkau R; Ost P; Gaipl U; Deutsch E
J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33188037
[TBL] [Abstract][Full Text] [Related]
33. Neutrophil-Lymphocyte Ratio Is a Prognostic Marker in Patients with Locally Advanced (Stage IIIA and IIIB) Non-Small Cell Lung Cancer Treated with Combined Modality Therapy.
Scilla KA; Bentzen SM; Lam VK; Mohindra P; Nichols EM; Vyfhuis MA; Bhooshan N; Feigenberg SJ; Edelman MJ; Feliciano JL
Oncologist; 2017 Jun; 22(6):737-742. PubMed ID: 28533476
[TBL] [Abstract][Full Text] [Related]
34. Pretreatment neutrophil-to-lymphocyte ratio predicts the benefit of gastric cancer patients with systemic therapy.
Du S; Fang Z; Ye L; Sun H; Deng G; Wu W; Zeng F
Aging (Albany NY); 2021 Jul; 13(13):17638-17654. PubMed ID: 34245559
[TBL] [Abstract][Full Text] [Related]
35. Neutrophil-to-Lymphocyte Ratio as a Prognostic Indicator in Patients With Unresectable Gastric Cancer.
Murakami Y; Saito H; Shimizu S; Kono Y; Shishido Y; Miyatani K; Matsunaga T; Fukumoto Y; Fujiwara Y
Anticancer Res; 2019 May; 39(5):2583-2589. PubMed ID: 31092456
[TBL] [Abstract][Full Text] [Related]
36. Prognostic value of neutrophil-to-lymphocyte ratio in advanced oesophago-gastric cancer: exploratory analysis of the REAL-2 trial.
Grenader T; Waddell T; Peckitt C; Oates J; Starling N; Cunningham D; Bridgewater J
Ann Oncol; 2016 Apr; 27(4):687-92. PubMed ID: 26787231
[TBL] [Abstract][Full Text] [Related]
37. EPSILoN: A Prognostic Score Using Clinical and Blood Biomarkers in Advanced Non-Small-cell Lung Cancer Treated With Immunotherapy.
Prelaj A; Rebuzzi SE; Pizzutilo P; Bilancia M; Montrone M; Pesola F; Longo V; Del Bene G; Lapadula V; Cassano F; Petrillo P; Bafunno D; Varesano N; Lamorgese V; Mastrandrea A; Ricci D; Catino A; Galetta D
Clin Lung Cancer; 2020 Jul; 21(4):365-377.e5. PubMed ID: 32245624
[TBL] [Abstract][Full Text] [Related]
38. Systemic inflammation is associated with the density of immune cells in the tumor microenvironment of gastric cancer.
Choi Y; Kim JW; Nam KH; Han SH; Kim JW; Ahn SH; Park DJ; Lee KW; Lee HS; Kim HH
Gastric Cancer; 2017 Jul; 20(4):602-611. PubMed ID: 27665104
[TBL] [Abstract][Full Text] [Related]
39. Pretreatment neutrophil-lymphocyte count ratio may associate with gastric cancer presence.
Jiang Y; Xu H; Jiang H; Ding S; Zheng T
Cancer Biomark; 2016 Mar; 16(4):523-8. PubMed ID: 27062567
[TBL] [Abstract][Full Text] [Related]
40. Blood neutrophil-lymphocyte ratio predicts survival for stages III-IV gastric cancer treated with neoadjuvant chemotherapy.
Jin H; Zhang G; Liu X; Liu X; Chen C; Yu H; Huang X; Zhang Q; Yu J
World J Surg Oncol; 2013 May; 11():112. PubMed ID: 23705622
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
